<DOC>
	<DOC>NCT01448954</DOC>
	<brief_summary>This study is to examine the safety, tolerability, pharmacokinetics and functional activity of ADC3680B administered once daily for 28 days in subjects with partly controlled atopic asthma.</brief_summary>
	<brief_title>A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Partially controlled mildmoderate atopic asthma Receiving inhaled corticosteroids Nonsmoker or former smoker Males and females aged 18 to 55 years inclusive If female, must be of nonchildbearing potential History of acute severe asthma attacks History of COPD Other serious respiratory or other medical condition which may interfere with the outcome of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>